For research use only. Not for therapeutic Use.
Des(sulfonylethyl)amino Hydroxy Lapatinib(CAT: C000143) holds significance in the realm of pharmaceutical chemistry, particularly in the context of cancer treatment. It is related to Lapatinib, a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. Lapatinib is utilized to treat breast cancer, particularly metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy options.
Catalog Number | C000143 |
CAS Number | 320337-48-2 |
Synonyms | 5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furanmethanol; |
Molecular Formula | C₂₆H₁₉ClFN₃O₃ |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) |
Appearance | Pale Yellow to Light Yellow Solid |
Storage | -20°C, Inert atmosphere |
Reference | Konecny, G., et al.: Cancer Res., 66, 1630 (2006); Geyer, C., et al.: N. Engl. J. Med., 355, 2733 (2006); |